← SynDRA
OLITIGALTIN
SynDRA canonical compound SYN0039594 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | LGALS3 |
| Mechanism of action | anti-inflammatory agent |
All known targets
Mechanisms of action (all sources)
- LGALS3 INHIBITOR
- Galectin-3 inhibitor
- anti-inflammatory agent
Cross-references
Synonyms
- Olitigaltine
- Olitigaltina
- TD-139
- TD139
- GB-0139
- GB0139
- (2R,2'R,3R,3'R,4S,4'S,5R,5'R,6S,6'S)-6,6'-Thiobis(4-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol)
- (2S,3R,4S,5R,6R)-4-[4-(3-Fluorophenyl)triazol-1-yl]-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,5-diol
- .BETA.-D-GALACTOPYRANOSIDE, 3-DEOXY-3-(4-(3-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL)-.BETA.-D-GALACTOPYRANOSYL 3-DEOXY-3-(4-(3-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL)-1-THIO-
- 3,3'-DIDEOXY-3,3'-BIS-(4-(3-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL)-1,1'-SULFANEDIYL-DI-.BETA.- D-GALACTOPYRANOSIDE
- 3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-Beta-D-Galactopyranosyl 3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-1-Thio-Beta-D-Galactopyranoside
- 60Y0GUO72B
- A857944
- AC-35516
- AKOS027325618
- BDBM50581762
- beta-D-Galactopyranoside, 3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-beta-D-galactopyranosyl 3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-1-thio-
- BIS(3-DEOXY-3-(3-FLUOROPHENYL-1H-1,2,3-TRIAZOL-1-YL)-.BETA.-D-GALACTOPYRANOSYL)SULFANE
- bis-(3-deoxy-3-(3-fluorophenyl-1h-1,2,3-triazol-1-yl)-beta-d-galactopyranosyl)-sulfane
- BS-15429
- BT173009
- C72753
- CHEMBL4297442
- CS-6265
- DB12895
- EX-A1688
- Gal-3 Inhibitor GB0139
- Galectin-3 Inhibitor GB0139
- GTPL12148
- HY-19940
- OLITIGALTIN [INN]
- Olitigaltin [USAN]
- Q27263259
- SCHEMBL15657269
- TD 139 [WHO-DD]
- TD2
- UNII-60Y0GUO72B
- WHO 12032
Look up OLITIGALTIN in the interactive SynDRA portal →